Fig. 2 | Scientific Reports

Fig. 2

From: Combination of gut microbiota, proinflammatory cytokine, and 18F-FDG PET as potential indicators for predicting breast cancer recurrence

Fig. 2

The process of identifying microbiome biomarkers that differ between the DFS and recurrence groups. A. Identification of specific biomarkers for DFS and recurrence groups through LefSe analysis. B. Prevotella abundance differs between the DFS and recurrence groups. C. Comparison of Prevotella abundance between groups with high and low IL-1β levels. D. Difference in Prevotella abundance between groups with high and low CRP levels.

Back to article page